SGLT2 Inhibitor

The reason she doesn't like losartan as much is because it's a shorter acting medication. So should be dose twice a day, but like olemosartan, talmosartan, candisartan, those ones are longer acting. She said, vousartan is a little bit of a weaker agent. That's another reason she didn't use that one. And so that's a, that's a great option for these guys. We have, we've got study after study and he's kind of the prototypical patient that's been enrolled. The SGLT2 inhibitor has shown no decrease effectiveness at low GFR.